Additionally, as ASSESS-AKI participant CHIP status was ascertained using a targeted sequencing method that is highly sensitive to small CHIP clones, we conducted a sensitivity analysis examining only large clones with a VAF ≥ 10%. This evidence concerns the gene STUB1 and acute kidney injury.